metabolic health – The Milli Chronicle

Tuesday, January 6, 2026

Latest:

Maduro Faces U.S. Drug Charges in New York as Venezuela Adjusts to Power Shock
Russia Reassesses Global Strategy After Losing Venezuela Ally Amid U.S. Power Play
Iran’s Leadership Faces Mounting Pressure as Protests Intensify and U.S. Actions Abroad Raise Alarm
Switzerland Freezes Assets Linked to Venezuela’s Maduro as International Pressure Mounts
Bird Flu Outbreaks Raise Fresh Poultry and Public Health Concerns in Southern India

Factual Version of a Story

Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill

The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United

Asia Latest News

NewsDesk Milli Chronicle November 7, 2025November 7, 2025 Cipla, diabetes care India, diabetes control, diabetes treatment India, Eli Lilly, Eli Lilly India, GLP-1 drugs, healthcare growth India, healthcare technology, Hyderabad health innovation, India pharma market, medical innovation, metabolic health, Mounjaro, Novo Nordisk, obesity awareness, obesity treatment, pharmaceutical sales India, Wegovy, weight management therapy, weight-loss drug India, weight-loss injection

Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation

Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a

Pfizer Strengthens Its Bid for Metsera, Reinforces Commitment to Innovation in Obesity Treatment

Pfizer’s strategic move to revise its bid for Metsera underscores its dedication to advancing next-generation obesity therapies and fostering competition